• Info
  • Insider Ownership

Insider Trading & Ownership of Martin H. Huber Jr.

Location
Cambridge, MA
Summary
The estimated net worth of Martin H. Huber Jr. is at least $818,867 dollars as of 15 Sep 2025. Martin H. Huber Jr. is the Director of Syndax Pharmaceuticals Inc and owns shares of Syndax Pharmaceuticals Inc (SNDX) stock worth about $710.2K. Martin H. Huber Jr. is the President, CEO, Director of Mersana Therapeutics, Inc. and owns shares of Mersana Therapeutics, Inc. (MRSN) stock worth about $108.7K.
Signature
/s/ Alejandra Carvajal, Attorney-in-Fact
All Insider Reports
All Insider Reports

Notify me when Martin H. Huber Jr. files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Martin H. Huber Jr.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SNDX Syndax Pharmaceuticals Inc Director $710,210 +$44,950 +6.8% 19 May 2025
MRSN Mersana Therapeutics, Inc. President, CEO, Director $108,657 -$2,618 -2.4% 11 Sep 2025
XLO Xilio Therapeutics, Inc. President And Head Of R&D 16 Aug 2023

Insider Transactions Reported by Martin H. Huber Jr.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.